Record revenue of $56.1M in 3QFY22; Increase of 60% over $35.0M in Fiscal 2021 --
-- Orders increased 53% in 3QFY22 over fiscal 2021 to $59.7M --
-- Increases revenue guidance to $203 million for full year fiscal 2022 --
https://www.biospace.com/article/releases/twist-bioscience-reports-fiscal-third-quarter-2022-financial-results/
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.